Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 271.00
Bid: 0.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 32.00 (11.94%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 271.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update and Board Update

14 Jan 2021 07:00

RNS Number : 6235L
Synthomer PLC
14 January 2021
 

14th January 2021

 

Synthomer plc

 

Pre-Close Trading Update and Board Update

 

FY2020 EBITDA guidance raised c.10%; FY2020 proforma leverage expected to reduce further

Calum MacLean to stand down as Chief Executive by January 2022

 

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the year ended 31st December 2020 ahead of announcing the Group's Full Year results on 4th March 2021. Synthomer also announces that following 6 successful years, Calum MacLean has informed the Board that he intends to stand down as Chief Executive by January 2022.

 

Strong trading momentum across the business

 

Performance Elastomers

 

Performance Elastomers has continued to perform strongly. The positive trends experienced in our Nitrile latex business during the year continued through the final quarter of 2020 with overall performance ahead of expectations. Similarly, the conditions in our SBR latex business also continued to strengthen, with all SBR segments except paper trading ahead of the comparative period in 2019.

 

Functional Solutions

 

Functional Solutions has seen a sustained improvement in the final quarter of 2020 with our consumer facing and industrial end markets remaining strong with exception of the Oil and Gas business unit. We have seen activity levels above normal seasonal levels with overall performance ahead of expectations.

 

Industrial Specialities

 

Industrial Specialities also had a strong finish to the year, with our laminates and films business, which serves the home improvement and recreational vehicles market, trading particularly well and the division performing ahead of the equivalent period in 2019. 

 

FY 2020 EBITDA guidance raised and proforma leverage expected to reduce further

 

The combination of stronger trading across our three major divisions means that the Group now expects its 2020 EBITDA to be approximately £255m, some 10% ahead of the Company guidance of £232m provided in our trading statement of 14th October 2020.

 

The Group remains highly cash generative and now expects proforma leverage to reduce to circa 1.9x net debt to EBITDA as of 31st December 2020.

 

Outlook

 

Whilst the Group will continue to adapt its operations in response to the ongoing COVID-19 pandemic to ensure the safety of all employees, at this stage it expects no meaningful disruption to business. The Board is confident that the benefits of the OMNOVA acquisition, recent investment in new capacity, further efficiency measures, its proven growth strategy as well as continued strength in Performance Elastomers, will underpin strong EBITDA growth in 2021.

 

Board update

 

Having informed the Board that he would like to stand down as Chief Executive, Calum MacLean will leave the business by January 2022 when a successor is in place. During his 6 years as Chief Executive, Calum has driven significant change at Synthomer presiding over substantial investment and several acquisitions, notably Omnova in 2020. The process to find a new Chief Executive is underway and is expected to include both internal and external candidates. A further announcement will be made in due course.

 

Commenting Calum MacLean, Chief Executive, said:

 

"It has been a privilege to lead Synthomer for the last 6 years and I am proud of what we have achieved. With Omnova fully integrated, all core parts of the business growing and our financial outlook strong, now is the right time to hand over to someone else who can build on this exciting momentum. I look forward to welcoming my successor into the role when the time comes."

 

Commenting, Caroline Johnstone, Chair of Synthomer, said:

 

"In a very challenging year, Synthomer has delivered a strong performance, testament to the strategy that we have been consistently executing and the investments that we have made over the last five years. As we embark upon a new year and look further ahead to the future, the business is in a strong position.On behalf of the Board, I would like to thank Calum for everything that he has done to take Synthomer forward since joining at the start of 2015. His leadership and vision have transformed the business into a truly diversified, differentiated and global company. The next chapter promises to be just as exciting and the Board looks forward to working with a new Chief Executive in due course."

 

-ENDS-

 

Further information:

 

Calum MacLean, Chief Executive Officer

Steve Bennett, Chief Financial Officer Tel: + 44 1279 436211

Tim Hughes, President, Corporate Development

 

Charles Armitstead/ Matt Denham, Teneo Tel: + 44 7703 330 269/ + 44 7825 735596

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIILIIVLIL
Date   Source Headline
7th Apr 201110:01 amRNSHolding(s) in Company
7th Apr 20119:15 amRNSAnnual Financial Report
31st Mar 20113:48 pmRNSAcquisition
30th Mar 20114:38 pmRNSHolding(s) in Company
18th Mar 20114:28 pmRNSHolding(s) in Company
15th Mar 20111:42 pmRNSHolding(s) in Company
15th Mar 201110:15 amRNSHolding(s) in Company
14th Mar 201111:22 amRNSHolding(s) in Company
14th Mar 201111:20 amRNSEBT Share Purchase
9th Mar 20117:00 amRNSFinal Results
8th Mar 201111:58 amRNSHolding(s) in Company
8th Mar 20119:17 amRNSDirector Declaration
2nd Mar 20114:47 pmRNSHolding(s) in Company
2nd Mar 201110:27 amRNSAcquisition
15th Feb 20119:40 amRNSAcquisition of Polymer Latex
31st Jan 201112:16 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
20th Jan 201111:26 amRNSHolding(s) in Company
20th Jan 201111:24 amRNSHolding(s) in Company
18th Jan 20114:19 pmRNSHolding(s) in Company
18th Jan 20119:58 amRNSResult of Equity Issue
17th Jan 20115:28 pmRNSResult of Equity Issue
14th Jan 20111:21 pmRNSHolding(s) in Company
13th Jan 20114:33 pmPRNCorrection : Disclosure of Short Position
5th Jan 201112:15 pmRNSDirector/PDMR Shareholding
4th Jan 20111:03 pmRNSHolding(s) in Company
30th Dec 201011:31 amRNSResult of EGM
16th Dec 20105:15 pmRNSHolding(s) in Company
16th Dec 20105:13 pmRNSHolding(s) in Company
16th Dec 20105:05 pmRNSHolding(s) in Company
13th Dec 20105:12 pmRNSPublication of Prospectus
13th Dec 20107:00 amRNSAcquisition and Rights Issue
23rd Nov 201011:42 amRNSHolding(s) in Company
11th Nov 20107:00 amRNSInterim Management Statement
16th Sep 20109:37 amRNSHolding(s) in Company
14th Sep 201010:31 amRNSHolding(s) in Company
26th Aug 20105:42 pmRNSAppointment of Senior Independent Director
26th Aug 20107:00 amRNSHalf Yearly Report
28th Jun 20101:18 pmRNSDirectorate Change
24th Jun 20107:00 amRNSPre-close Trading Update
2nd Jun 20108:54 amRNSCompletion of disposal
6th May 201012:32 pmRNSResult of AGM
6th May 201011:00 amRNSInterim Management Statement
30th Apr 201012:40 pmRNSAnnual Information Update
8th Apr 20107:00 amRNSAnnual Financial Report
12th Mar 20107:00 amRNSDisposal
11th Mar 201010:32 amRNSDirector/PDMR Shareholding
11th Mar 201010:31 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSFinal Results
11th Feb 201012:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.